+ All Categories
Home > Documents > PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage...

PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage...

Date post: 28-Dec-2015
Category:
Upload: camron-hart
View: 215 times
Download: 0 times
Share this document with a friend
Popular Tags:
53
PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator
Transcript
Page 1: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

PRESENTATION II NAME

By Christine Harvey

Dihydrofolate Reductase Beta lactmasep300Macrophage Infectivity Potentiator

Page 2: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Dihydrofolate Reductase

in Escherichia coli

Page 3: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

http://en.wikipedia.org/wiki/DHFR

• Class: oxidoreductase

• Reduces dihydrofolate (DHF) to tetrahydrofolate (THF)

• THF is a precursor to amino acids, purine and thymidylate.

• DHFR is imperative to cell life

Page 4: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Function

Source: Schweitzer, Barry I., et al. The FASEB Journal Vol 4, “Dihydrofolate reductase as a therapeutic target.” May 1990.

Page 5: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Mechanism

http://en.wikipedia.org/wiki/DHFR

Page 6: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Structure

Page 7: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Binding Pocket

Page 8: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 10: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 11: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 12: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 13: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 14: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Sequence Alignment

Page 15: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Phylogenetic Tree

Page 16: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Beta-Lactamasein Escherichia coli

Page 17: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

• Class: Hydrolase

• Beta Lactamase is produce by bacteria after being exposed to beta lactam antibiotics

• Responsible for beta lactam antibiotic resistance

Page 18: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Penicillin

• Contains beta lactam ring

Page 19: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Mechanism

Page 20: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 21: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

21

Page 22: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 23: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 24: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 25: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 26: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 27: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 28: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

p300In Homo Sapiens

Page 29: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

• Class: Transferase

• p300 transfers an acetyl group from acetyl coenzyme A to an active site lysine

• Transcriptional activation occurs upon acetyl transfer

Page 30: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Title

• p300 is responsible for cell growth before and after birth

• Cancer suppressor

Page 31: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Domains

Taz2

KIX

Bromodomain

HAT

Zinc Fingers (3)

Taz2

Creb

Page 32: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Histone Acetyl Transferase

• Active site tyrosine acts as nucleophile

Source: http://www.bmolchem.wisc.edu/labs/denu/images/hats/sequential.jpg

Page 33: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 34: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 35: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 36: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 37: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Docking

Page 38: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 39: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

39

Page 40: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Macrophage Infectivity Potentiator

in Legionella pneumophila

Page 41: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Legionella pneumophila

• gram negative bacteria

• Causes Legionnaires’ disease

• Carried in aerosols from man-made water systems

Page 42: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

MIP

• Class: Isomerase

• Catalyzes the isomeration of the N-terminal on proline

• Cause of virulence in Legionnaires’ disease

• Located on outer membrane protein

• 25 kDa

Page 43: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Crystalization

• Solution: 100 mM MES (pH 6.1–6.5), 15–20% (w/v) PEG 8000 and 500 mM zinc acetate. Protein concentration was 10 mg ml–1in 20 mM HEPES, pH 7.0

• Crystals were grown for 2-3 weeks at 288K

• X-ray data was collected at 100K in a nitrogen gas stream (dried paraffin oil) at 2.4 Angstrom resolution

• Multiwavelength anomalous dispersion (MAD) with zinc was used for phasing

Page 44: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

44

Source: Riboldi-Tunnicliffe, Alan et al., Nature Structural Biology, vol.8: 9. “Crystal structure of Mip, a prolylisomerase from Legionella pneumophila.” September 2001.

Page 45: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Mechanism

• Peptidyl-prolyl cis-trans isomerases’ (PPIases) mechanism is not currently know

Source: Park, Steven T., et al. Journal of Biological Chemistry. Vol. 267 No.5, “PPIase Catalysis by Human Fk506-binding Protein Proceeds Through a Conformational Twist Mechanism.” February 1992.

Page 46: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

Source: Riboldi-Tunnicliffe, Alan et al., Nature Structural Biology, vol.8: 9. “Crystal structure of Mip, a prolylisomerase from Legionella pneumophila.” September 2001.

Page 47: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 48: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 49: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

49

Page 50: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.
Page 51: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

51

Page 52: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

52

Page 53: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.

53

Questions?


Recommended